Numedii Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Numedii Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11211
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Numedii Inc (Numedii) is a life science technology company that discovers and develops new drug candidates by translating life sciences big data into therapies. The company uses life sciences big data technology to discover and de-risk molecular entities based on therapeutically relevant biological networks. It utilizes broad human clinical and molecular network data to drive discovery. Numedii also discovers new uses for drug candidates, which have been discontinued or de-prioritized. The company has research and development collaborations with various pharmaceutical and biotech companies and patient-centric organizations to create pipeline and new products through the use of its discovery technology.. Numedii is headquartered in San Mateo, California, the US.

Numedii Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Numedii Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Numedii Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Numedii Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Numedii Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Numedii Inc, Medical Devices Deals, 2012 to YTD 2018 9
Numedii Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Numedii Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
NuMedii Raises US$3.5 Million In Series A Financing 11
Partnerships 12
NuMedii Enters into Research Collaboration with Johns Hopkins School of Medicine 12
Numedii Enters into Agreement with Three Lakes Partners 13
Numedii Enters into Agreement with Pharma Company 14
NuMedii Enters into Agreement with Astellas Pharma 15
NuMedii Enters into Research Agreement with Allergan 16
NuMedii Enters Into Co-Development Agreement With Aptalis Pharma 17
Numedii Inc – Key Competitors 18
Numedii Inc – Key Employees 19
Numedii Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Jun 20, 2018: NuMedii Expands Board of Directors and Scientific Advisory Board with the Addition of Two Oncology Experts 21
Jan 08, 2018: World’s Leading Lung Disease Experts Join NuMedii’s Idiopathic Pulmonary Fibrosis Advisory Board 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Numedii Inc, Pharmaceuticals & Healthcare, Key Facts 2
Numedii Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Numedii Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Numedii Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Numedii Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Numedii Inc, Medical Devices Deals, 2012 to YTD 2018 9
Numedii Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NuMedii Raises US$3.5 Million In Series A Financing 11
NuMedii Enters into Research Collaboration with Johns Hopkins School of Medicine 12
Numedii Enters into Agreement with Three Lakes Partners 13
Numedii Enters into Agreement with Pharma Company 14
NuMedii Enters into Agreement with Astellas Pharma 15
NuMedii Enters into Research Agreement with Allergan 16
NuMedii Enters Into Co-Development Agreement With Aptalis Pharma 17
Numedii Inc, Key Competitors 18
Numedii Inc, Key Employees 19

List of Figures
Numedii Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Numedii Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Numedii Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Numedii Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Numedii Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Numedii Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Numedii Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Numedii Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Numedii Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Numedii Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Topy Industries Ltd:企業の戦略・SWOT・財務分析
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Pentax Europe GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Pentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corp, is a medical device company that offers clinical endo-imaging solutions. The company provides products in the therapeutic areas of gastroenterology, endoscopic ultrasound, ENT and speech, pulmonology and urology, among others. I …
  • Taisei Lamick Co., Ltd.:企業の戦略・SWOT・財務情報
    Taisei Lamick Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taisei Lamick Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析
    Summary Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly Isotechnika Pharma Inc, is a clinical stage biopharmaceutical company which develops and commercializes therapies for the treatment of diseases with high unmet medical need. Its pipeline products include Voclosporin, is an inves …
  • Tav Havalimanlari Holding AS:戦略・SWOT・企業財務分析
    Tav Havalimanlari Holding AS - Strategy, SWOT and Corporate Finance Report Summary Tav Havalimanlari Holding AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Grupo Televisa, S.A.B. (TLEVISACPO):企業の財務・戦略的SWOT分析
    Grupo Televisa, S.A.B. (TLEVISACPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Fenwal Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fenwal Inc (Fenwal), a subsidiary of Fresenius Kabi AG is a blood technology company that supports transfusion medicine and cell therapies. The company’s products include amicus separator, blood pack units with whole blood filter, mononuclear cell collection, alyx component collection system …
  • The British United Provident Association Ltd:企業の戦略的SWOT分析
    The British United Provident Association Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Nanomerics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Nanomerics Ltd (Nanomerics) is a healthcare solution provider that develops drug delivery solutions for poorly water soluble drugs, nucleic acids and peptides. The company offers products such as METDoloron, METSporine, METAmphizon, METEnkalon, MET undisclosed, MET ocular undiscl, ocular und …
  • Berlin Packaging, LLC.:企業の戦略・SWOT・財務情報
    Berlin Packaging, LLC. - Strategy, SWOT and Corporate Finance Report Summary Berlin Packaging, LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Enviva Partners LP (EVA):企業の財務・戦略的SWOT分析
    Enviva Partners LP (EVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Parkland Fuel Corp (PKI):石油・ガス:M&Aディール及び事業提携情報
    Summary Parkland Fuel Corp (Parkland) is a downstream energy company. It markets various fuel and petroleum products, including gasoline, propane, lubricants, diesel, heating oil, and other petroleum products. The company maintains a portfolio of supply relationships, storage infrastructure, and thi …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Asahi Kasei Corp (3407)-エネルギー分野:企業M&A・提携分析
    Summary Asahi Kasei Corp (Asahi Kasei), formerly Asahi Chemical Industry Co. Ltd., manufactures, processes, and sells chemical products. It is a holding company of Asahi Kasei Group. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation …
  • Redbiotec AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing prod …
  • Eloro Resources Ltd (ELO):企業の財務・戦略的SWOT分析
    Summary Eloro Resources Ltd (Eloro Resources) is a mining and minerals exploration and development company that offers mineral exploration and development services. The company acquires, explores and develops precious and base-metal resources properties across Quebec. It explores for titanium, silve …
  • Compass Group PLC:戦略・SWOT・企業財務分析
    Compass Group PLC - Strategy, SWOT and Corporate Finance Report Summary Compass Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Therapix Biosciences Ltd (TRPX):製薬・医療:M&Aディール及び事業提携情報
    Summary Therapix Biosciences Ltd (Therapix), formerly Nasvax Ltd is a clinical stage biopharmaceutical company that focuses on the development of cannabinoid based pharmaceuticals for the treatment of central nervous system disorders. Therapix’s major product candidates include THX-110, for the trea …
  • Tufts University-製薬・医療分野:企業M&A・提携分析
    Summary Tufts University (Tufts) is an educational and research university that offers undergraduate and postgraduate courses in various fields. The university offer courses in anthropology, applied mathematics, architectural engineering, physics, archaeology, Asian American studies, biochemistry, b …
  • Grieg Seafood ASA:企業の戦略・SWOT・財務情報
    Grieg Seafood ASA - Strategy, SWOT and Corporate Finance Report Summary Grieg Seafood ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆